Changes in AIDS Survival Time in Two San Francisco Cohorts of Homosexual Men, 1983 to 1993
JAMAPublished 13 April 1994
Dennis Osmond
Citations101
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Survival time from a CD4 lymphocyte count at 0.20 x 10(9)/L has improved significantly by about 1 year; yet survival time using the 1987 AIDS case definition has shown small improvement.
Abstract
Survival time from a CD4 lymphocyte count at 0.20 x 10(9)/L has improved significantly by about 1 year; yet survival time using the 1987 AIDS case definition has shown small improvement. The largest increase in survival time from a CD4 lymphocyte count at 0.20 x 10(9)/L was in patients diagnosed with PCP, suggesting that PCP prophylaxis and treatment were more important factors in longer survival time than antiretroviral therapy.
Keywords
Medicine
Clinical Infectious Diseases1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults
4,356 Citations1993K. G. Castro, Jill Ward +5 more
The classification system for HIV infection is revised to emphasize the clinical importance of the CD4+ T-lymphocyte count in the categorization of HIV-related clinical conditions and the AIDS surveillance case definition is expanded.
New England Journal of MedicineThe Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
2,982 Citations1987Margaret A. Fischl, Douglas D. Richman +12 more
It is demonstrated that AZT administration can decrease mortality and the frequency of opportunistic infections in a selected group of subjects with AIDS or AIDS-related complex, at least over the 8 to 24 weeks of observation in this study.
New England Journal of MedicineZidovudine in Asymptomatic Human Immunodeficiency Virus Infection
1,293 Citations1990Paul A. Volberding, Stephen W. Lagakos +18 more
Zidovudine is safe and effective in persons with asymptomatic HIV infection and fewer than 500 CD4+ cells per cubic millimeter and additional study will be required to determine whether such treatment will ultimately improve survival for persons infected with HIV.
PubMedSurveillance for dracunculiasis, 1981-1991.
1,111 Citations1992Hopkins Dr, Ernesto Ruiz‐Tiben
Methods for conducting surveillance of dracunculiasis and other important diseases must continue to be developed and improved as countries now believed to be free of dracanculiasis prepare to apply to WHO for certification of elimination.
BMJSeropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort
548 Citations1988Andrew R. Moss, Peter Bacchetti +7 more
It is concluded from the observed rates and the distribution of predictive variables at three years that half of the men who were seropositive for HIV will develop AIDS by six years after the start of the study, and three quarters will developAIDS or an AIDS related condition.
NatureIncubation period of AIDS in San Francisco
386 Citations1989Peter Bacchetti, Andrew R. Moss
A non-parametric implementation of this strategy produced an estimate of the incubation distribution of HIV infections in San Francisco's gay community with a median at 9.8 years, increasing hazard rates, and less uncertainty than previous estimates.
JAMASexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study
374 Citations1987Warren Winkelstein
New England Journal of MedicineA Controlled Trial of Trimethoprim–Sulfamethoxazole or Aerosolized Pentamidine for Secondary Prophylaxis of<i>Pneumocystis carinii</i>Pneumonia in Patients with the Acquired Immunodeficiency Syndrome
347 Citations1992William D. Hardy, Judith Feinberg +12 more
In patients with AIDS who are receiving zidovudine, trimethoprim-sulfamethoxazole is more effective than aerosolized pentamidine in conventional doses for the prevention of recurrent pneumocystis infection.
New England Journal of MedicineA Controlled Trial of Early versus Late Treatment with Zidovudine in Symptomatic Human Immunodeficiency Virus Infection
329 Citations1992John D. Hamilton, Pamela Hartigan +18 more
In symptomatic patients with HIV infection, early treatment with zidovudine delays progression to AIDS, but in this controlled study it did not improve survival, and it was associated with more side effects.
New England Journal of MedicineA Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome
328 Citations1990Margaret A. Fischl, Corette B. Parker +15 more
A randomized controlled trial in 524 subjects who had had a first episode of Pneumocystis carinii pneumonia found that the efficacy and safety of a reduced dose of zidovudine were superior to the standard-treatment group and the low-dose group.
New England Journal of MedicineZidovudine and the Natural History of the Acquired Immunodeficiency Syndrome
286 Citations1991Richard D. Moore, Julia Hidalgo +2 more
For Maryland residents with AIDS there has been an improvement in survival since 1987 and zidovudine therapy and perhaps other aspects of care associated with it have contributed substantially to the improved survival.
New England Journal of MedicineA Controlled Trial of Aerosolized Pentamidine or Trimethoprim–Sulfamethoxazole as Primary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with Human Immunodeficiency Virus Infection
280 Citations1992M. M. E. Schneider, Andy I. M. Hoepelman +7 more
For patients with HIV infection, trimethoprim-sulfamethoxazole taken once a day is more effective as primary prophylaxis against PCP than aerosolized pentamidine administered once a month, although adverse drug reactions are more frequent with trimethobrim- sulfamETHoxazol.
JAMASurvival Trends for Patients With AIDS
267 Citations1990George F. Lemp
It is suggested that survival following diagnosis of acquired immunodeficiency syndrome has improved in recent years, primarily among patients with carinii pneumonia, and therapy with zidovudine may be partially responsible for these recent improvements.
ScienceA Model-Based Estimate of the Mean Incubation Period for AIDS in Homosexual Men
240 Citations1988Kung‐Jong Lui, William W. Darrow +1 more
A model for the proportion likely to develop AIDS and the incubation period for AIDS in homosexual men could be derived and is close to the estimate of 8.2 years for adults developing transfusion-associated AIDS.
American Journal of EpidemiologyRISK FACTORS FOR AIDS AND HIV SEROPOSITIVITY IN HOMOSEXUAL MEN
182 Citations1987Andrew R. Moss, Dennis Osmond +4 more
Cases of acquired immunodeficiency syndrome diagnosed in San Francisco, California, during 1983-1984 with human immuno-deficiency virus (HIV) antibody-negative neighborhood and clinic controls, looking for risk factors for clinical AIDS and seropositivity were compared.
JAMASurvival Experience Among Patients With AIDS Receiving Zidovudine
165 Citations1988Terri Creagh-Kirk
Comparison with available natural history data suggests that zidovudine therapy is associated with increased 44-week survival of post-PCP patients with acquired immunodeficiency syndrome.
Journal of the American Statistical AssociationHierarchical Bayes Models for the Progression of HIV Infection Using Longitudinal CD4 T-Cell Numbers
150 Citations1992Nicholas Lange, Bradley P. Carlin +1 more
This work model longitudinal series of CD4 T-cells as a marker of disease progression for persons infected with the human immunodeficiency virus for a sample of 327 subjects in the San Francisco Men's Health Study and develops an approach to Bayesian model choice and individual prediction.
The Journal of Infectious DiseasesSurvival Patterns of the First 500 Patients with AIDS in San Francisco
107 Citations1988Peter Bacchetti, Dennis Osmond +5 more
Les taux de survie rapportes dans cet article sont inferieurs a ceux rapporte dans la ville de New York ― 45% a New York contre 30% a San Francisco ― pour une survie de 1 an.
PubMedClinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study.
102 Citations1987William Lang, Robert E. Anderson +6 more
Archives of Internal MedicinePneumocystis Prophylaxis and Survival in Patients With Advanced Human Immunodeficiency Virus Infection Treated With Zidovudine
59 Citations1992Richard E. Chaisson
Pneumocystis cariniipneumonia during follow-up was strongly associated with death when controlling for other factors, and consistent use of each was associated with improved survival.
JAMAImmunodeficiency and the Risk of Death in HIV Infection
59 Citations1992A. N. Phillips
In patients with HIV infection who are closely followed up, the risk of death is low before the CD4 lymphocyte count has fallen to 0.05 x 10(9)/L, a count many patients remain above up to 12 years after seroconversion.
American Journal of Public HealthEffect of changing patterns of care and duration of survival on the cost of treating the acquired immunodeficiency syndrome (AIDS).
39 Citations1990George R. Seage, Stewart Landers +2 more
Although the cost per patient per year decreased between years one and two, median survival increased by 70 percent and overall estimated lifetime costs increased by 24 percent.